Novavax Inc

Ownership Transactions Reported by 21 Insiders

Symbol
NVAX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Quince Orchard Road, Gaithersburg, MD

Insiders trading volume in the past year

Novavax Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John C. Jacobs President and CEO, Director $19.5M Mar 3, 2025
Elaine O'Hara EVP, Chief Strategy Officer $4.65M Mar 3, 2025
James Patrick Kelly EVP, CFO and Treasurer $3.29M Mar 7, 2025
Ruxandra Draghia-Akli Section 16 $2.78M Mar 3, 2025
Mark J. Casey EVP, Chief Legal Officer $2.6M Mar 3, 2025
Filip Dubovsky President, R&D $1.23M Jun 17, 2024
Stanley C. Erck President and CEO, Director $1.18M Dec 14, 2022
John Trizzino President and COO $809K Mar 7, 2025
James F. Young Director $807K -$82.2K -9.25% Dec 24, 2024
John A. Herrmann III EVP, Chief Legal Officer $759K Dec 14, 2023
David M. Mott Director $704K Jun 20, 2025
Douglas Richard Director $663K Jun 20, 2025
Gregory M. Glenn President, R&D $599K Mar 6, 2023
John W. Shiver Director $521K Mar 10, 2025
Gregg H. Alton Director $505K Jun 20, 2025
Margaret G. Mcglynn Director $485K Jun 20, 2025
Rachel King Director $483K -$37.4K -7.2% Jun 20, 2025
Richard J. Rodgers Director $365K Jun 20, 2025
Gary C. Evans Director $83.3K Jun 17, 2021
Michael A. Mcmanus Jr Director $63.6K Jun 16, 2022
Charles W. Newton Director Apr 25, 2025

Recent Insider Transactions by Companies or Individuals for Novavax Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.